title: Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Hattori
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Miyakawa
authors.forename: Kenji
authors.initials: K
authors.lastname: Yokoyama
authors.forename: Taketo
authors.initials: T
authors.lastname: Yamada
authors.forename: Wenlin
authors.initials: W
authors.lastname: Du
authors.forename: Masahiro
authors.initials: M
authors.lastname: Jinzaki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shinmoto
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Okamoto
mesh_terms: D000328:Adult; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage*; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D011446:Prospective Studies; D013792:Thalidomide / Q000008:administration & dosage*
chemical_list: D020533:Angiogenesis Inhibitors; D018931:Antineoplastic Agents, Hormonal; D013792:Thalidomide; D011239:Prednisolone